ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

HCM HUTCHMED China Limited

18.12
-0.52 (-2.79%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
HUTCHMED China Limited HCM NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-0.52 -2.79% 18.12 06:39:55
始値 安値 高値 終値 前日終値
18.37 18.01 18.45 18.12 18.64
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0719:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0709:00GLOBEHUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506..
2024/6/0319:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0309:00GLOBEHUTCHMED Highlights Publication of Phase III FRUTIGA Results..
2024/5/3119:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2419:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2409:00GLOBEHUTCHMED Highlights Presentations at the 2024 ASCO Annual..
2024/5/1723:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/1723:00GLOBEHUTCHMED announces retirement of Chairman, appointment of..
2024/5/1709:00GLOBEHUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and..
2024/5/1409:00GLOBEHUTCHMED Initiates the RAPHAEL Registrational Phase III..
2024/5/0817:30GLOBEHUTCHMED Announces Appointment of Independent Non-executive..
2024/4/2621:30GLOBEHUTCHMED Announces Positive CHMP Opinion for Fruquintinib in..
2024/4/0517:30GLOBEHUTCHMED Highlights Data to be Presented at..
2024/4/0213:30GLOBEHUTCHMED and Innovent Jointly Announce NDA Acceptance in..
2024/3/2809:00GLOBEHUTCHMED Announces Savolitinib sNDA Accepted in China for..
2024/3/2209:00GLOBEHUTCHMED Initiates Registration Stage of the ESLIM-02 Phase..
2024/3/0520:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2820:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2820:40EDGAR2Form 20-F - Annual and transition report of foreign private..
2024/2/2820:30GLOBEHUTCHMED Reports 2023 Full Year Results and Provides..
2024/2/0720:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0709:00GLOBEHUTCHMED Highlights Presentation of Phase III Data on..
2024/2/0220:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0217:30GLOBEHUTCHMED Announces that Inmagene Exercises Option to License..
2024/2/0120:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0117:30GLOBEHUTCHMED to Announce 2023 Final Results
2024/1/3020:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/3013:53GLOBEHUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval..
2024/1/1120:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1116:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
2024/1/1109:00GLOBEHUTCHMED Announces NDA Acceptance in China for Sovleplenib..
2023/12/2920:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2120:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1316:00RNSNONHutchmed (China) Limited Completed Enrollment of Phase..
2023/12/1313:30GLOBEHUTCHMED Announces Continued Inclusion of ELUNATE®..
2023/12/1309:00GLOBEHUTCHMED Announces that it has Completed Enrollment of a..
2023/12/0720:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0120:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0116:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
2023/12/0109:00GLOBEHUTCHMED Highlights Clinical Data to be Presented at 2023..
2023/11/3020:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1022:35GLOBEDeutsche Bank ADR Investor Conference: Presentations Now..
2023/11/0920:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0909:11GLOBEHUTCHMED Announces that Takeda Receives U.S. FDA Approval of..
2023/11/0121:35GLOBEInternational companies to host live webcasts at Deutsche..
2023/10/2419:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1619:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1617:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..

最近閲覧した銘柄

Delayed Upgrade Clock